JDRF and Type 1 Diabetes Clinical TrialsJDRF has launched an online service to connect folks with type 1 diabetes to clinical trials related to type 1.
The JDRF Clinical Trials Connection site gives you an opportunity to participate in trials that may lead to better treatments for type 1 diabetes. I know from participating in clinical trials at the Joslin Diabetes Center and for Dr. Faustman that many of these trials have problems recruiting qualified individuals.
According to the press release I received: "people can provide criteria like the type of trial they are interested in, how long they have had diabetes, and how far they’d be willing to travel, and the site will let them know about studies that match those characteristics. Clinical Trials Connection can help them search for trials, compare one trial with another, and update them on new trials that might match their interest. Plus, the service provides contact information for the researchers conducting the trial, so people interested in trials can contact them directly for more information, after discussing options with their healthcare provider."
The site also includes the following public service announcement ad about clinical trials.
Initial registration at the clinical trials site requires your name, email address and date of birth. After getting your password by email, you then enter much more details including: your date of birth (again); whether you or a family member has type 1 diabetes; date of diagnosis; address; states you would travel to for trials and other details.
I registered and the search for trials turned up the following five:
- Study of Islet Transplantation in Type 1 Diabetic Kidney Transplant Recipients
- Comparison of Lantus and NPH Insulin in the Dawn Phenomenon
- Closed-Loop Glucose Control for Automated Management of Type 1 Diabetes
- Imaging Inflammation in Autoimmune Diabetes
- Glycemic Stability of Insulin Aspart Versus Insulin Lispro in Insulin Pump Therapy
What have you got to lose? I'd strongly recommend registering so that you can move the state of diabetes research forward.